Summary
Plasma growth-hormone levels in 12 fasting psoriatics were 4.4±1.4 mU/l (mean±SEM), compared to 2.7±1.7 in 5 patients with eczema and 1.2±0.3 in 6 normal subjects. The differences in mean values were not statistically significant and were due to exceptionally high levels of growth hormone in five patients with psoriasis and one patient with eczema. In the psoriatic group the exceptional patients were not distinguished by age or the area of involved skin but they tended to be leaner than those with low plasma-growth hormone levels. We conclude that raised plasma growth hormone cannot be the cause of psoriasis but might be a secondary effect of the skin disease in some patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Franks S (1979) Prolactin. In: Gray CH, James VHT (eds) Hormones in blood, vol 1. Academic Press, New York, pp 280–331
Glinski IN, Zarebska Z, Jablonska S, Imiela J, Nosarzewski J (1980) The activity of polymorphonuclear leucocyte neutral proteinases and their inhibitors in patients with psoriasis treated with a continuous peritoneal dialysis. J Invest Dermatol 75: 481–487
Holzmann H, Eissner D, Hahn K, Thiers G, Böhm G (1982) The psoriatic bone manifestation. In: Farber EM, Cox AJ (eds) Psoriasis. Proceedings of the Third International Symposium. Grune and Stratton, New York, pp 335–336
Hopsu-Havu VK, Terho PE, Vanha-Perttula TP, Vilganen MK (1973) Response of blood insulin and growth hormone to glucose infusion in normal, psoriatic and diabetic persons. Acta Derm Venereol (Stockholm) 53:39–44
Hopsu-Havu VK, Niinikoski A, Haapalahti JE, Jansen CT (1973) Serum insulin and growth hormone response to arginine infusion in healthy and psoriatic persons. Dermatologica 146:205–210
Hunter WM (1976) Growth hormone. In: Lorraine JA, Bell ET (eds) Hormone assays and their application, 4th edn. Churchill Livingstone, Edinburgh, pp 221–284
Hunter WM (1976) Radioimmunoassay of growth hormone (HGH) in plasma. In: Bruer H, Hamel D, Kruskemper HC (eds) Methods of hormone analysis. Georg Thieme, Stuttgart; Wylie, New York, pp 1–11
Hwang P, Guyda H, Friesen H (1971) A radioimmunoassay for human prolactin. Proc Natl Acad Sci USA 68:1902–1906
Kreuger GG (1981) Psoriasis. In: Dobson RL, Thiers BH (eds) Yearbook of dermatology. Yearbook Medical Publishers, Chicago, pp 13–70
MacKie RM, Beastall GM, Thomson JA (1983) Growth hormone levels in psoriasis. Arch Dermatol Res 275:207
Namey TC, Rosenthal L (1976) Periarticular uptake of 99m-technetium diphosphonate in psoriatics: correlation with cutaneous activity. Arthritis Rheum 19:607–612
Weber G, Neidhardt M, Schmidt A, Geiger A (1981) The correlation of growth hormone and clinical picture in psoriasis. Arch Dermatol Res 270:129–140
Weber G, Klughardt G, Niedhardt M (1981) Psoriasis and human growth hormone: aetiology and therapy. Arch Dermatol Res 270:361–365
Weber G, Neidhardt M, Frey H, Galle K, Geiger A (1981) Treatment of psoriasis with bromocriptin. Arch Dermatol Res 271:437–439
Weber G, Klughardt G, Neidhardt M, Galle R, Frey H, Geiger A (1982) Treatment of psoriasis with somatostatin. Arch Dermatol Res 272:31–36
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Priestley, G.C., Gawkrodger, D.J., Seth, J. et al. Growth hormone levels in psoriasis. Arch Dermatol Res 276, 147–150 (1984). https://doi.org/10.1007/BF00414010
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00414010